Macrophage activation syndrome and post-transplant microangiopathy following haploidentical bone marrow transplantation for sickle cell anemia
Main Authors: | Davies, J, Hart, A, De La Fuente, J, Bain, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2017
|
Similar Items
-
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
by: Ashley Munchel, et al.
Published: (2011-06-01) -
HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION - INVIVO CONDITIONING WITH MONOCLONAL-ANTIBODIES
by: Fasth, A, et al.
Published: (1988) -
Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation
by: Nidhi Sharma, et al.
Published: (2021-06-01) -
A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform
by: Hisanori Mayumi
Published: (2021-09-01) -
Bone Marrow Transplantation for Aplastic Anemia
by: Rainer Storb M.D.
Published: (1993-09-01)